Wellesley Pharmaceuticals is focused on developing a treatment for Nocturia, a medical condition for excessive urination during the night.
Investors 1
| Date | Name | Website |
| - | Keiretsu F... | keiretsufo... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 14.07.2021 | P&G Ve... | Did you miss a session from th... | - | Dean Takah... | venturebea... |
| 14.07.2021 | P&G Ve... | We are excited to bring Transf... | - | Dean Takah... | venturebea... |